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In  the preceding publication  (1)  the  results  of  studies  on  the  kinetics  of 
iron metabolism (2-5)  in normal growing  swine were reported. The purpose 
of this paper is  to present the results of similar  studies in  swine with  three 
different types of experimentally induced anemias. As an example of a  severe 
hemolytic process with no detectable impairment in the capacity of the bone 
marrow  to  produce  erythrocytes,  anemia  induced  by the  administration of 
phenylhydrazine (6) has been studied.  The kinetics of iron metabolism have 
been  studied  also  in  swine  with  anemia  due  to  a  deficiency of  pyridoxine 
(6--8)  and in  swine with anemia  due  to a  deficiency of pteroylglutamic acid 
(9-11). The last  two anemias are quite different morphologically. That ane- 
mia  associated  with  pyridoxine  deficiency is  microcytic  and  hypochromic, 
whereas  that  occurring in  pteroylglutamic acid  deficiency is  macrocytic. In 
both,  the  plasma  iron  level is  greatly elevated,  there  is  a  reduction in  the 
amount  of  free protoporphyrin in  the  erythrocytes, and  there  is  erythroid 
hyperplasia  in  the  bone  marrow.  However,  the  tissues  of  the  pyridoxine- 
deficient animals are heavily laden with iron, whereas hemosiderin deposits are 
not prominent in the tissues of swine deficient in pteroylglutamic acid. 
These studies were carried out in the hope of gaining an understanding of 
the pathogenesis of the anemia  in  these conditions and also with the expec- 
tation  that  these  anemias  of  known  and  singular  etiology might  serve  as 
patterns  of  reference for  anemias  which  develop  in  human  subjects.  In  a 
later publication (12) iron kinetics will be described in copper-deficient swine. 
The  anemia  accompanying  that  condition  is  microcytic  and  hypochromic 
and the level of iron in the plasma and tissues is low. 
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between the United States Atomic Energy Commission and the University of Utah and in 
part by a research grant (C-2231) from  the National Cancer Institute, National Institutes of 
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Methods 
Nine swine of the  Chester-White breed were  used  in this study.  Pteroylglutamie acid 
deficiency was produced by feeding a  26 per cent "purified" casein diet supplemented with 
sulfasuxidine and crude methyl folic acid antagonist (10). The diet used for the production of 
pyridoxine deficiency has been described previously (6). The animals given phenylhydrazine 
were fed the standard 26 per cent crude casein diet with a  complete vitamin and mineral 
supplement (13). 
TABLE  I 
Data from Which Ferrokinetic Calculations Were Made 
Bod  Growth  Plasma  Red cell  Volume  Hemo-  Plasma 
packed  globin  iron  Group  Pig No.  weight  rate  volume  volume  red cells 




28.8  0.33  47.7  -4-  30.4  -4-  37.6  -4-  12.7  -4-  166  -4- 
8.5  5.4  3.0  1.0  52 
(8.6-  (0.10-  (33.9-  (20.0-  (34.2-  (10.7-  (95-295) 
97.0)  0.64)  60.3)  44.9)  47.0)  14.4)' 
~Iemolytic ane-  13-37  32.7  0.08  69.5  20.8  22.2  5.4  323 
mia (phenyl-  13-38  26.4  O. 04  44.4  18.1  26.6  7.6  89 
hydrazine)  13-39  25.0  0.07  77.7  27.3  29.0  7.4  66 
Mean ....  28.0  0.06  63.9  22.1  25.9  6.8  159 
?yridoxine-de-  13-43  8.5  O. 10  68.8  15.0  9.0  2.9  552 
ficient  13-44  10.9  0.00  50.5  18.8  19.0  5.9  676 
13-45  9.0  0.00  72.2  13.8  10.6  3.6  526 
Mean.  9.5  0.03  63.8  15.8  12.8  4.1  585 
?teroylglutamic  13-53  18.8  0.00  55.9  15.9  20.8  6.1  696 
acid--deficient  13-87  13.5  0.32  50.0  14.1  21.5  7.1  470 
13-88  13.8  0.24  56.9  10.9  15.9  5.7  539 
Mean..  15.4  0.18  54.3  13.6  19.4  6.3  568 
* -~ one standard deviation. 
Phenylhydrazine was administered orally to 3 of the swine in daily doses during the week 
prior to the ferrokinetic study. 2 gm. per day was given for the first 2 days. Thereafter, the 
dose was adjusted daily so that the volume of packed red cells was between 20 and 30 ml./100 
ml. at the time of the ferrokinetic study. 
Hematologic studies (red cell count, hemoglobin concentration, volume of packed red cells, 
calculation of the corpuscular constants, reticulocyte, total leukocyte, and differential leuko- 
cyte counts) were performed weekly. In addition, the volume of packed red cells and hemo- 
globin concentration were determined daily during the ferrokinetic study. 
The techniques used in this study and the calculation of the data were the same as those 
described in the preceding publication (1)  with the exception that the radioiron was prein- 
cubated with plasma from normal swine because of the possibility that the iron-binding pro- 
tein in the animals with experimentally induced anemias might already be saturated. 
Data concerning the individual pigs are given in Table I. BUSH, JENSEN, ASHENBRUCKER,  CARTWRIGHT,  AND WINTROBE  163 
RESULTS 
PhenylhydrazineJnduced  Hemolytic  A nemia.--The  plasma  iron level was 
elevated in  1 of the  animals  (13-37)  and  reduced  in  2  (Table  I). The ferro- 
kinetic  data  are presented  in  Table II. In  all 3  of the  pigs  the  radioactive 
iron disappeared rapidly from the plasma and the plasma iron turnover rate, 
expressed  in  milligrams  of  plasma  iron  turned  over  per  kilogram  of  body 
weight per day, was greatly increased as compared with that of normal pigs. 
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FIo. 1.  Per cent of the administered dose of radioiron incorporated into the erythrocytes 
of normal and anemic swine. The vertical bars on the mean normal uptake curve represent 
one standard deviation. 
The  rate  of  incorporation  of radioiron  into  the  erythrocytes  is  shown  in 
Fig.  1. All 3  of the animals incorporated the isotope into red cells more rap- 
idly than did the normal pigs, and plateau concentrations were reached sooner. 
An  average  of 86  per  cent  of  the  administered  activity  was  ultimately  in- 
corporated as compared with 92 per cent in the normal animals. This differ- 
ence in the amount incorporated by the two groups is probably not significant 
since it is likely that some of the labelled red cells in the anemic animals were 
hemolyzed as soon as they were released into the circulation. 164  IRON METABOLISM  IN SWINE WITH ANEMIA 
The average amount of iron incorporated into red cells daily by the anemic 
animals was 4.23 mg./kg, of body weight, a  value 4.2 times the normal mean. 
Of  this  amount,  4.14  mg.  or  97  per  cent  was  turning  over  through  the  red 
cells since only 0.10 mg./kg, was accounted for by growth of the animals. By 
calculation, the average RBC  life span in the animals given phenylhydrazine 
was 5  days as compared with a  mean of 63 days in the normal pigs. 
TABLE II 
Ferrokinetic Data in Swine with Anemia 





FE  ~0 in-  Iron incor-  RBC 
corpo-  RBC  IIR§  porateddue  RBC ITRU  life  rated  into  to  growth  span 
RBC 
hrs.  mg./kg,  day  mg./kg,  day  mg./kg, day  rag./kg, day  days 
1.19  1.11  92  1.01  0.42  0.59  63 
0.72-1.67 0.40-1.6672-10C  ~.40-1.66 0.03--0.85 0.32-1.03 34--100 
~emolytic  13-37  0.53  7.06  79  [  5.58  0.04  5.54  3 
anemia¶  13-38  0.22  2.98  80  I  3.38  0.02  2.36  7 
13-39  0.18  4.74  100  4.74  0.23  4.51  6 
Mean.  0.31  4.93  86  4.23  0.10  4.14  5 
?yfidoxine-  13-43  1.25  5.01  6  0.30  0.10  0.20  44 
defident  13-44  2.08  2.71  8  0.22  0.00  0.22  64 
13-45  1.13  5.55  5  0.28  0.00  0.28  38 
Mean ....  1.49  4.42  6  0.27  0.03  0.23  49 
P.G.A.-**defi-  13-53  1.10  5.97  36  2.15  0.00  2.15  8 
cient  13-87  0.70  5.58  35  1.95  0.36  1.59  11 
13-88  1.03  4.93  14  0.69  0.22  0.47  31 
Mean ....  0.94  5.49  28  1.60  0.19  1.40  17 
* The time at which the concentration of Fe  ~9 in the plasma had decreased to 
initial value. 
~; Plasma iron turnover rate. 
§ Red cell iron incorporation rate. 
[I Red cell iron turnover rate. 
¶ Due to the ingestion of phenylhydrazine. 
** Pteroylglutamic add. 
half of its 
Anemia Due to Pyridoxine Deficiency.--The plasma iron level was elevated 
in  all 3  animals  (Table  I).  The  ferrokinetic data  are presented in Table  II. 
In  2  of  the  pigs  the  radioiron  disappeared from  the  plasma  at  the normal 
rate. The  disappearance rate in the 3rd animal  (13-44)  was slower than nor- 
mal. The  plasma iron turnover  rate was greatly increased in all 3  pigs. The 
rate  of  incorporation  of  iron  into  erythrocytes  was  slower  than  in  normal BUSH, JENSEN, ASHENBRUCKER, CARTWRIGHT, AND WINTROBE  165 
animals and an average of 6  per cent of the administered radioactivity was 
ultimately incorporated into  the  red  cells as  compared with  92  per  cent in 
the normal pigs.  The average amount of iron incorporated into erythrocytes 
each day was 0.27  mg./kg,  of body weight or only about one-fourth of the 
average amount incorporated into the erythrocytes of the normal swine. The 
average life span  of the erythrocytes was  calculated to be 49 days,  a  value 
within the normal limits. 
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FIG. 2.  Body surface radioactivity in 2 normal pigs and in 2 pigs deficient in pteroylglutamic 
acid (P.G.A.). 
Anemia Due to a Deficiency of Pteroylglutamic Acid.--The  plasma iron level 
was  elevated  in  all  3  animals  (Table  I)  and  the  radioactivity disappeared 
from the plasma at a  normal rate in 2 pigs and at a  slightly reduced rate in 
1 animal  (13-87). The plasma iron turnover rate was about 5  times the nor- 
mal mean  in  all 3  of the pigs  (Table II).  The rate  of incorporation of iron 
into erythrocytes was slower than in normal animals and an average of only 
28 per cent of the administered isotope was  incorporated into the  red  cells. 
However, the  amount  of iron  incorporated into  red  cells  each  day  was  in- 
creased beyond the upper limit of normal in 2 pigs and was within the nor- 
mal range in 1 of them. After adjustment for the growth of the animals,  the 
amount of iron turned over through  the red cells each  day was found to be I66  IRON METABOLISM IN SWINE WITH ANEMIA 
increased in 2 and normal in 1 pig (13-88). The average amount of iron turned 
over  through  the  red  cells by  the  3  pigs  was  approximately twice normal. 
The calculated red cell life span was shortened in all three animals. The mean 
value was 17 days as compared with 63 days in the normal pigs. 
Body  surface  radioactivity  was  determined  over  the  liver,  spleen,  and 
sacral  bone  marrow  sites  of  two  of  the  pteroylglutamic acid-deficient  pigs. 
The results  are  presented in  Fig.  2  and  are  compared with  the  results  ob- 
tained in 2 normal swine. No significant difference was noted in the rate of 
uptake  of  radioiron  into  the  three  sites  as  compared with  that  in  normal 
animals.  Although  the  height  of  the  initial  peak  was  somewhat  higher  in 
the deficient animals than in the normal ones, this difference is probably not 
significant since  the  deficient animals  had  less  subcutaneous  tissue  and  the 
counter was closer to the target organ. The rate of release of the isotope from 
the liver, spleen,  and sacral bone marrow sites of the deficient animals was 
greatly retarded. 
DISCUSSION 
In  the  previous  publication  (1)  the  assumptions  and  errors  involved  in 
ferrokinetic  studies  were  discussed.  Ferrokinetic  calculations  are  made  on 
the  assumption  that  the  rate  of production of cells is  equal  to  the  rate  of 
their destruction, and therefore, that  red cell volume is constant.  To main- 
tain anemic animals in a  state of hemopoietic equilibrium for any period of 
time is indeed difficult. On the other hand, the deficient animals and the ani- 
mals  given phenylhydrazine grew very little,  if at  all,  during  the period of 
study.  In  order  to  make  the  data  comparable  to  those  in  rapidly  growing 
control animals we have corrected for the small degree of growth of the ane- 
mic pigs although this correction does not modify the data significantly. 
The ferrokinetic studies revealed striking differences between the 3 experi- 
mentally  induced  anemias.  In  the  animals  given  phenylhydrazine  the  life 
span  of  the  erythrocytes was  shortened markedly. The values obtained for 
the life span  in  these animals  are  only approximate because it was difficult 
to maintain a constant volume of packed red ceils during the period of study. 
Furthermore,  when  the  life  span  of  the  erythrocytes is  shortened  so  dras- 
tically it  is  difficult to  determine the  exact proportion  of isotope which  is 
incorporated into the red cells since a portion of the cells is destroyed as rap- 
idly as they are labelled and discharged into the blood (2). Finally, the deter- 
mination of the red cell volume with P3~-tagged red cells may not be accurate 
under such  conditions since some of the  tagged cells may be rapidly elimi- 
nated with the result that the value may be falsely high. 
Animals given phenylhydrazine incorporated 4.2  times as much iron into 
hemoglobin per day as did the normal pigs. Since this rate of production was 
not sufficient to prevent the development of anemia it is likely that this was 
the maximum rate at which the bone marrows of these animals could produce BUSH~ JENSEN, ASHENBRUCKER,  CARTWRIGHT, AND WlNTROBE  167 
hemoglobin. If one assumes that 100 per cent of the iron turned over through 
the plasma  actually entered  the bone marrow for use in erythropoiesis, the 
red  cell output,  as measured  by the  red  blood cell iron incorporation rate, 
increased fivefold. If it is assumed  that  the phenylhydrazine did not impair 
the  capacity of the marrow to produce erythrocytes, then the bone marrow 
of normal swine can increase the output of red cells by  a  factor of four  to 
five. This value is  similar  to,  but a  little less  than,  that  estimated in man 
(14). This means that if the capacity of the marrow to produce cells is not 
impaired, the marrow can compensate for a  reduction in the life span of the 
cells  to  one-fourth or one-fifth of the  normal  value.  Since  the  life span  of 
porcine erythrocytes is  normally about  63  days  (1,  13),  a  normal  marrow 
should be able  to produce enough erythrocytes to prevent the  development 
of anemia if the life span is not shorter than 13 to 16 days. 
The  ferrokinetic pattern  in  the  pyridoxine-deficient swine  was  quite  dif- 
ferent from  that  in  the  animals  given  phenylhydrazine.  In  this  deficiency 
the life span of the cells was within normal limits, and only 0.27 rag. of iron 
per kg. of body weight per day was incorporated into hemoglobin. Therefore, 
these animals  were producing about  one-fourth as much hemoglobin as  the 
normal animals and about one-sixteenth as much as the animals given phen- 
ylhydrazine. Thus, the anemia in this deficiency was  due  to  an  inability  of 
the marrow to produce a  normal number of cells. 
The high plasma  iron turnover rate in pyridoxine deficiency is interesting 
in view of the fact that only about 0.4 per cent of the iron which was turned 
over each  day  through  the  plasma  appeared  in  the  erythrocytes. Two  ex- 
planations  for this phenomenon come to mind.  It is known  that  the  tissue 
stores of iron are greatly increased in pyridoxine deficiency (7) and it is pos- 
sible that  there is a  rapid  turnover between the plasma  and  the  tissue iron. 
The other explanation is  that  the  iron  goes to  the  marrow,  is  incorporated 
into heme, and then the heme is catabolized before it can appear in the  cells 
in  the  circulation.  That  this is  an  unlikely explanation is  indicated  by  the 
observation that the excretion of bile pigment is not increased (6). 
Pyridoxine deficiency in swine differs from aplastic anemia in human sub- 
jects in  that in  the latter condition the plasma  iron turnover rate is normal 
or  decreased  (2,  5).  It  does,  however,  from a  kinetic  standpoint,  resemble 
the refractory pancytopenia associated with a  cellular marrow (5). 
The  mean  survival  time  of  the  erythrocytes of  the  animals  deficient  in 
pteroylglutamic acid  was decreased to an average of 17 days. However, the 
bone marrow was  able  to increase its production rate  only about  1.6  times 
the normal rate. Thus, anemia developed because of two defects: a  decrease 
of the erythrocyte survival time and a  limitation of the capacity of the bone 
marrow to increase  the production of cells to the same extent as in the ani- 
mals given phenylhydrazine. 
The similarities between the ferrokinetic patterns in pteroylglutamic acid- 168  IRON METABOLISM IN  SWINE  WITH ANEMIA 
deficient swine and patients with pernicious anemia in relapse  are  striking. 
In both conditions the plasma iron level is increased (6,  8,  15),  the amount 
of iron turned over through the plasma each day is increased (2,  16, 17), the 
red cell uptake of radioiron is low (2), the red cell iron turnover rate is normal 
or increased only slightly (2),  and the  survival time of the erythrocytes is 
shortened (18-20).  It has been suggested by several observers (5,  16, 21, 22) 
that there may be rapid destruction of red cell precursors in the marrow of 
patients with pernicious anemia. If such is the case,  there would be an iron 
compartment in  the marrow with a  short turnover time through which re- 
cycling of iron would take place. This would account for the excessive turn- 
over of iron through the plasma. Our data in the pteroylglutamic acid-defi- 
cient swine could also be  interpreted in this manner.  If this interpretation 
is correct, it would be expected that the excretion of bile pigment would be 
increased  as  it  is  known  to  be  in  pernicious  anemia.  Unfortunately,  such 
measurements have not been made in pteroylglutamic acid-deficient swine. 
Another explanation for the fivefold increase in the plasma iron turnover 
rate in the presence of a  mean red cell  iron incorporation of only 1.6 times 
normal is that there is considerable exchange of iron between the non-hemo- 
globin tissues and the plasma. The body surface counts do not help to clarify 
this problem since the delivery of isotope from the bone marrow was retarded 
to the same degree as that from the liver and spleen. Furthermore, it is pos- 
sible  that much of the activity attributed to the liver and spleen was due to 
the proximity of the ribs to these sites (1). 
In the past, the anemias of nutritional origin have been classified  as being 
due  to  decreased red  cell  production  (23,  24).  The  data  presented  in  this 
paper suggest that the pathogenesis of all types of anemia due to nutritional 
deficiency may not be  similar.  A  shortened erythrocyte life span  has  now 
been demonstrated not only in anemia due to pteroylgintamic acid deficiency 
in swine but also in swine deficient in copper  (12),  in scorbutic human sub- 
jects with anemia  (25,  26),  and in patients with pernicious anemia (18-20). 
Thus, it is apparent that decreased blood production is not the only factor 
involved in the pathogenesis of some anemias of nutritional origin, although 
this is apparently the only factor involved in the pathogenesis of the anemia 
due  to  a  deficiency O  f  pyridoxine in  swine.  Current  knowledge concerning 
the kinetic pattern in various forms of nutritional anemia in man and swine 
is summarized in Table III. 
The mechanisms whereby the life span of erythrocytes is decreased in the 
different deficiency states have  not been  adequately studied.  Those  studies 
which have been done suggest that the mechanism may not be the same in 
each deficiency. Studies in this laboratory (12)  on the nature of the hemo- 
lytic mechanism of  the  anemia  of  copper  deficiency in  swine  suggest  that 
the  defect  is  primarily  intracorpuscular.  Studies  by  the  Ashby  technique BUSH, JENSEN, ASHENBRUCKER,  CARTWRIGHT, AND WINTROBE  169 
indicate that normal red cells are  destroyed at an accelerated rate  in scor- 
butic individuals (25).  Data  are not  available on the survival of cells  from 
patients with scurvy transfused into normal subjects.  Several observers  (18, 
19)  have demonstrated that the life span of cells from a  patient with perni- 
cious anemia,  transfused into a  normal recipient, is moderately impaired. It 
has  been  suggested  that,  in  addition  to  the  intracorpuscular  defect in  this 
disease,  there is an extracorpuscular hemolytic mechanism (27). 
Several general observations can be  made from the ferrokinetic data ob- 
tained in  this  study.  The  PITR  was  increased  to  approximately  the  same 
extent in each experimental group and yet red cell production ranged from 
markedly reduced to markedly increased. Thus, it is apparent that the plasma 
iron turnover rate is of no value in the estimation of the rate of erythropoie- 
TABLE IH 




Pteroylglutamic  acid 
(swine) 
Vitamin Bls (human sub- 
jects) 















RBC iron turnover rat~ 
Decreased 
Increased slightly 
Normal or slightly 
increased 
Normal or slightly 
increased 
Erythrocyte 






sis.  The uptake of Fe  59 into the red cells  was markedly reduced in pteroyl- 
glutamic acid deficiency and yet the production of red cells was apparently 
greater than in the normal animMs. Thus,  the uptake of radioiron by itself 
is of no value in predicting the rate of red cell synthesis. A  complete study 
must be performed in order to understand the kinetic pattern. 
S~RY 
Ferrokinetic studies were performed  on 3  swine  given phenylhydrazine, 
3  swine  deficient in pyridoxine, and  3  swine  deficient in pteroylglutamic 
acid. Body  surface radioactivity was measured  in 2 pteroylglutamic  acid- 
deficient  animals. 
In  the  animals  given  phenylhydrazine,  the mean  erythrocyte  survival 
time was 5 days.  The plasma iron  turnover rate was increased about fourfold, 
and the rate of erythropoiesis was four to five times greater than that in 
the control  pigs. 
In  the  pyridoxine-deficient swine, the  mean  erythrocyte  survival time 
was within the limits of normal. The plasma iron turnover rate was increased 170  IRON METABOLISM IN  SWINE  WITH ANEMIA 
fourfold,  but  the  rate  of  erythropoiesis was  approximately  one-fourth  the 
normal mean value. These data are interpreted as indicating that the anemia 
associated with this deficiency is a  result of an inability of the bone marrow 
to produce a  normal number of erythrocytes. 
In  the  pteroylglutamic  acid-deficient  swine,  the  mean  erythrocyte sur- 
vival time was  17 days. The plasma iron turnover rate was 5 times the nor- 
mal mean value.  The rate  of erythropoiesis was  1.6  times greater than  the 
mean value in the control pigs. These data are interpreted as indicating  that 
anemia develops in this deficiency as a  result of a  combination of a  shorten- 
ing of the erythrocyte survival time and a  limitation of the capacity of the 
bone marrow to increase red cell production to the same degree as a  normal 
marrow. 
The radioactivity in the liver, spleen, and bone marrow of the pteroylglu- 
tamic  acid-deficient swine,  as  determined by  measurement  of  the  radioac- 
tivity over the body surface, declined more slowly than in control pigs. 
The authors are indebted to Dr. A. Gibson, Merck and Company, Inc., Rahway, New 
Jersey, for the supplies of thiamin hydrochloride,  riboflavin,  nicotinic acid, pyridoxine  hydro- 
chloride, calcium pantothenate,  inositol, para-amino-benzoic acid, choline chloride, and 
cobalamin; to Dr. T. H. Jukes, Lederie  Laboratories, Pearl River, New York, for the pteroyl- 
glutamic acid; to Dr. E. L. Severinghaus,  Hoffman-La  Roche, Inc., Nutley, New Jersey, for 
biotin and vitamins A, D, E, and K. 
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